Search
for
Sort by
Research 781–810 of 1000+
- Finasteride versus dutasteride: a real-world economic evaluation.
- Many sexual adverse effects of finasteride are attributable to a nocebo effect
- Sustainable UV approaches supported by greenness and whiteness assessments for estimating a recently FDA-approved combination for managing urologic disorders: Tukey's test
- The Dutasteride: Miraculous Drug in Alopecia Treatment A Review
- Synthesis of novel andostane-N-cyclohexyl-17-carboxamides, and their effect on the 5α-reductase isoform 2, the androgen receptor, and androgen-dependent glands
- Discovery of novel 5α-reductase type II inhibitors by pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulations
- Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
- Abstracts of the Final Year Projects of Pharm D Clinical Pharmacy Students Faculty of Pharmacy Beni-suef University Year 2024/2025
- Differential association between cumulative dose of 5α-reductase inhibitors and mortality
- Comment on “The post-finasteride syndrome: possible etiological mechanisms and symptoms”
- 40gm 미만의 전립선비대증에서 α-차단제와 Finasteride 병합요법의 유용성
- Validated HPTLC method for the simultaneous determination of alfuzosin, terazosin, prazosin, doxazosin and finasteride in pharmaceutical formulations
- An update on the use of 5alpha-reductase inhibitors
- Inhibitory effects of TripTripterygium wilfordii multiglycoside on benign prostatic hyperplasia in rats
- Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States
- Dutasteride Improves Nocturia but Does Not Lead to Better Sleep: Results from the REDUCE Clinical Trial
- Why Odds Ratios Can Be Tricky Statistics
- Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
- Finasterid in der Behandlung der benignen Prostatahyperplasie
- Editorial comment
- The Risk of Benign Prostatic Hyperplasia and Prostate Cancer With Long-Term, Low Dose Finasteride Use in Adult Men with Nonscarring Alopecia: A Propensity-Matched Observational Study
- Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
- Polygenic risk score predicting susceptibility and outcome of benign prostatic hyperplasia in the Han Chinese
- 피나스테라이드의 특성에 대한 이론적 연구
- Dutasteride: a guide to its use as monotherapy in benign prostatic hyperplasia
- Finasteride en mammacarcinoom bij mannen
- Influencia del tratamiento con alfa bloqueantes e inhibidores de la 5 alfa reductasa en los hallazgos morfológicos e inmunohistoquímicos de la hiperplasia benigna de próstata
- O que sabemos sobre os inibidores da 5 alfa redutase?
- PD20-08 INVESTIGATION OF SEXUAL DYSFUNCTION LINKED TO FINASTERIDE USE: A PHARMACOVIGILANCE ANALYSIS
- High Real-World Medication Adherence and Durable Clinical Benefit in Medicare Patients Treated with 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia